Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 235,035 | reported | 04 Dec 2020 | tx 31+790,533−434,259 |
| ELECTRO OPTICAL SCIENCES INC /NY | 109,724 | reported | 05 Jul 2023 | tx 6+520,848 |
| Clearside Biomedical, Inc. | 45,000 | reported | 20 Jun 2024 | tx 14+248,540−45,454 |
| Aclaris Therapeutics, Inc. | 33,525 | reported | 06 Jun 2025 | tx 28+222,980−33,525 |
| PhaseBio Pharmaceuticals Inc | 2,538 | reported | 19 May 2023 | tx 7+66,168−2,538 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | — | |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 42,350 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 11,580 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Clearside Biomedical, Inc. | 45,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,793 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | — | |
| 01 Jun 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 22 Sept 2023 | EXERCISE | Clearside Biomedical, Inc. | 22,727 | 0.40 USD | |
| 22 Sept 2023 | EXERCISE | Clearside Biomedical, Inc. | 22,727 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | ELECTRO OPTICAL SCIENCES INC /NY | 36,408 | 1.03 USD | |
| 22 Jun 2023 | GRANT_AWARD | Clearside Biomedical, Inc. | 30,000 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | — | |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,660 | 0.00 USD | deriv |
| 02 Jun 2023 | EXERCISE | Aclaris Therapeutics, Inc. | 4,507 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 2,538 | — | |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 2,538 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Clearside Biomedical, Inc. | 30,000 | 0.00 USD | deriv |
| 03 Jun 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,356 | — | |
| 02 Jun 2022 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 4,507 | 0.00 USD | deriv |
| 03 Jun 2022 | EXERCISE | Aclaris Therapeutics, Inc. | 3,356 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 15,750 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 24 Mar 2022.